A judge undid Kennedy's vaccine overhaul as measles, RSV and new COVID data all argue for vaccination.
A South Carolina health system study published in CID emulated a target trial, matching 10,029 vaccinated adults to twice as many unvaccinated, 30,080 in total, average age 65, with 85.6% having a preexisting condition. Vaccine effectiveness was 41% against emergency department or more severe care and 46% against hospitalization.
Answered around 27:44In a 45-page decision, Judge Murphy found the CDC acted unlawfully on January 5th when it cut routinely recommended childhood vaccinations without consulting ACIP, and that the committee was unlawfully constituted after Kennedy removed and replaced all 17 independent experts. Most of the 15 current members appear distinctly unqualified.
Answered around 9:20The court stays the CDC childhood immunization schedule that replaced the evidence-based, expert-guided one, the appointment of the 13 ACIP members Kennedy appointed, and all votes taken by that stayed committee. A legally constituted expert panel must be rebuilt and make recommendations before the CDC updates anything.
Answered around 12:38South Carolina's outbreak stands at 997 confirmed cases, almost 1,000, and Utah's current outbreak is up to 443. The Hopkins tracker counts 1,513 nationally while the CDC lists only 1,362, both updated March 13th, meaning the CDC is not counting all the measles cases.
Answered around 16:39A Cell paper showed patients previously hospitalized with severe COVID-19 had increased subsequent lung cancer, and murine models showed severe respiratory viral infection accelerates tumor growth while vaccination mitigated it. Prior viral pneumonia reprogrammed the lung into a pro-tumor environment with tumor-associated neutrophils and heightened immunosuppression.
Answered around 23:37In a Quebec healthcare worker cohort published in CID with 8,230 COVID-19 participants, pre-Omicron one and two dose efficacy was 75% and 95% against COVID-19, and 91% and 87% against long COVID. During Omicron a booster gave 41% and 57%; hybrid immunity ran 81% to 92%.
Answered around 29:57The FDA expanded approval to younger adults at high risk. Arexvy now covers everyone 75 and over, people 50 to 75 at risk, and at-risk adults from 18 to 49, such as those with chronic lung disease. Third trimester pregnancy is covered, and babies get the monoclonal.
Answered around 21:54Normally RSV starts in the southeast, in Florida around October, roughly ten weeks counting from July, peaks, then falls. This year, at the 36th week from July, it is still rising, with a woman admitted through the emergency room that day. It is unusual and hasn't happened before.
Answered around 20:51FAERS becomes AEMS, an adverse event monitoring system consolidating reporting for medical products, vaccines, devices, tobacco, food, cosmetics and veterinary medicines, with VAERS folded into it. In May the FDA expands AEMS to human food, dietary supplements, medical devices, tobacco and nicotine delivery systems, powered by artificial intelligence.
Answered around 4:26A randomized, double-blind trial in the US and Mongolia, published in the Journal of Nutrition, gave 9,600 IU daily for two days then 3,200 IU daily for four weeks, or placebo, to 1,747 index participants. Four-week healthcare utilization did not differ, and long COVID showed no significant impact.
Answered around 32:18“science is far from a perfect instrument of knowledge.”
“I don't believe that they've lost millions of dollars with a reporting system.”
“And so CDC is not counting all the measles cases. Does that shock you, Vincent?”
“No, expect them to hide things.”
“yeah, these are vaccine preventable, by and large.”
“So, yeah, would you like to reduce your chance of ending up in the hospital by half?”
“Bird Flu Die-Off and FDA Monitoring Update.” https://traffic.libsyn.com/secure/twiv/TWiV1306.mp3. Transcript summary by WhipScribe, https://whipscribe.com/transcript-pages/bird-flu-die-off-and-fda-monitoring-update.html.